Cargando…
Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations
The treatment of metastatic colorectal cancer (mCRC) harboring BRAF V600 mutations is challenging. These tumors are often refractory to standard treatment. Therefore, the patients may exhibit rapid clinical deterioration, depriving them of the chance to receive salvage therapy. In newly diagnosed pa...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579731/ https://www.ncbi.nlm.nih.gov/pubmed/33133378 http://dx.doi.org/10.4251/wjgo.v12.i10.1080 |